Literature DB >> 34741672

Feasibility of totally laparoscopic total gastrectomy in obese patients with gastric cancer.

Hideaki Suematsu1,2, Chikara Kunisaki3, Hiroshi Miyamato1, Kei Sato1, Sho Sato1, Yusaku Tanaka1, Norio Yukawa4, Yasushi Rino4, Takashi Kosaka5, Itaru Endo5, Munetaka Masuda4.   

Abstract

PURPOSE: This study aimed to evaluate the short- and long-term outcomes in obese patients with gastric cancer undergoing totally laparoscopic total gastrectomy (TLTG) to clarify its feasibility in this population.
METHODS: We examined 136 consecutive patients who underwent TLTG for gastric cancer (GC) between 2013 and 2018. A total of 45 patients with a body mass index (BMI) ≥ 25 kg/m2 were defined as the obese group (obese and overweight patients by the WHO classification), and 91 patients with a BMI < 25 kg/m2 were defined as the non-obese group. Short- and long-term outcomes were compared, and the correlation between obesity and postoperative complications was examined in patients who underwent TLTG.
RESULTS: Although the operation time (min) was significantly longer in the obese group than in the non-obese group (329 vs 307, p = 0.002), there were no significant differences in the total volume of blood loss (mL) (118 vs 60, p = 0.059) or the rate of conversion to laparotomy between the two groups (2 vs 2, p = 0.466). Moreover, there was no significant difference in the incidence of postoperative complications between the two groups (16% vs 19%, p = 0.653). In the multivariate analysis, obesity was not identified as a risk factor for postoperative complications among patients who underwent TLTG. The rate of overall survival was not significantly different between the groups (p = 0.512).
CONCLUSION: TLTG is feasible for obese Japanese patients with GC. To validate the results of the present study, it is necessary to conduct a prospective study of a large population of patients with GC.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Body mass index; Gastric cancer; Laparoscopic total gastrectomy; Obese

Mesh:

Year:  2021        PMID: 34741672     DOI: 10.1007/s00423-021-02369-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


  30 in total

1.  Systematic review and updated network meta-analysis of randomized controlled trials comparing open, laparoscopic-assisted, and robotic distal gastrectomy for early and locally advanced gastric cancer.

Authors:  Alberto Aiolfi; Francesca Lombardo; Kazuhide Matsushima; Andrea Sozzi; Marta Cavalli; Valerio Panizzo; Gianluca Bonitta; Davide Bona
Journal:  Surgery       Date:  2021-05-19       Impact factor: 3.982

2.  Does high body mass index negatively affect the surgical outcome and long-term survival of gastric cancer patients who underwent gastrectomy: A systematic review and meta-analysis.

Authors:  Bochao Zhao; Jingting Zhang; Di Mei; Rui Luo; Huiwen Lu; Huimian Xu; Baojun Huang
Journal:  Eur J Surg Oncol       Date:  2018-10-16       Impact factor: 4.424

3.  Application of Laparoscopic Gastrectomy in Obese Patients (BMI≥30 kg/m2) with Gastric Cancer: A Comparison With Open Gastrectomy Regarding Short-term Outcomes.

Authors:  Ke Chen; Yu Pan; Wei-Hua Yu; Xue-Yong Zheng; Ling-Hua Zhu; Xian-Fa Wang
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2018-02       Impact factor: 1.719

4.  Comparison of hand-assisted laparoscopic and open radical distal gastrectomy for obese patients.

Authors:  Guang-Tan Zhang; Dong Liang; Xue-Dong Zhang
Journal:  Am Surg       Date:  2013-12       Impact factor: 0.688

5.  Feasibility of laparoscopy gastrectomy for gastric cancer in the patients with high body mass index: A systematic review and meta-analysis.

Authors:  Lin Sun; Bochao Zhao; Youyi Huang; Huiwen Lu; Rui Luo; Baojun Huang
Journal:  Asian J Surg       Date:  2019-04-26       Impact factor: 2.767

6.  Effect of obesity on technical feasibility and postoperative outcomes of laparoscopy-assisted distal gastrectomy--comparison with open distal gastrectomy.

Authors:  Hiroyuki Yamada; Kazuyuki Kojima; Mikito Inokuchi; Tatsuyuki Kawano; Kenichi Sugihara
Journal:  J Gastrointest Surg       Date:  2007-10-23       Impact factor: 3.452

7.  Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.

Authors:  Hitoshi Katai; Junki Mizusawa; Hiroshi Katayama; Shinji Morita; Takanobu Yamada; Etsuro Bando; Seiji Ito; Masakazu Takagi; Akinori Takagane; Shin Teshima; Keisuke Koeda; Souya Nunobe; Takaki Yoshikawa; Masanori Terashima; Mitsuru Sasako
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-11-19

Review 8.  Laparoscopic-assisted versus open radical gastrectomy for resectable gastric cancer: Systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials.

Authors:  Hui-Zi Li; Jia-Xi Chen; Yang Zheng; Xiang-Nan Zhu
Journal:  J Surg Oncol       Date:  2016-04-13       Impact factor: 3.454

9.  Impact of body mass index on short-term outcomes of laparoscopic gastrectomy in Asian patients: A meta-analysis.

Authors:  Heng-Kai Chen; Guang-Wei Zhu; Yong-Jian Huang; Wei Zheng; Shu-Gang Yang; Jian-Xin Ye
Journal:  World J Clin Cases       Date:  2018-12-06       Impact factor: 1.337

10.  Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial.

Authors:  Nicole van der Wielen; Jennifer Straatman; Freek Daams; Riccardo Rosati; Paolo Parise; Jürgen Weitz; Christoph Reissfelder; Ismael Diez Del Val; Carlos Loureiro; Purificación Parada-González; Elena Pintos-Martínez; Francisco Mateo Vallejo; Carlos Medina Achirica; Andrés Sánchez-Pernaute; Adriana Ruano Campos; Luigi Bonavina; Emanuele L G Asti; Alfredo Alonso Poza; Carlos Gilsanz; Magnus Nilsson; Mats Lindblad; Suzanne S Gisbertz; Mark I van Berge Henegouwen; Uberto Fumagalli Romario; Stefano De Pascale; Khurshid Akhtar; H Jaap Bonjer; Miguel A Cuesta; Donald L van der Peet
Journal:  Gastric Cancer       Date:  2020-07-31       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.